Insights into Pacific Biosciences Q4 Earnings
Benzinga Insights 8 months ago
Earnings
Pacific Biosciences (NASDAQ:PACB) just disclosed its Q4 earnings on Thursday, February 12, 2026 at 04:05 PM.
Here's a brief overview of the earnings report.
Earnings
Pacific Biosciences beat estimated earnings by 25.0%, reporting an EPS of $-0.12 versus an estimate of $-0.16.
Revenue was up $5.42 million from the same period last year.
Performance in Previous Earnings
The company beat on EPS by $0.03 in the last quarter, resulting in a 7.05% drop share price change the following day.
Here's a look at Pacific Biosciences's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -0.17 | -0.19 | -0.21 |
| EPS Actual | -0.12 | -0.13 | -0.15 | -0.20 |
| Revenue Estimate | 40.08M | 36.47M | 36.90M | 40.16M |
| Revenue Actual | 38.44M | 39.77M | 37.15M | 39.22M |
To track all earnings releases for Pacific Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.